COMET strongly supported the development and implementation of medium-term topical research roadmaps consistent with the ALLIANCE Strategic Research Agenda.

J Radiol Prot

Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Santé et Environnement, Cadarache-Batiment 159, BP 3, F-13115 Saint-Paul-lez-Durance, France.

Published: March 2018

The ALLIANCE Strategic Research Agenda (SRA) initiated by the STAR Network of Excellence and integrated in the research strategy implemented by the COMET consortium, defines a long-term vision of the needs for, and implementation of, research in radioecology. This reference document, reflecting views from many stakeholders groups and researchers, serves as an input to those responsible for defining EU research call topics through the ALLIANCE SRA statement delivered each year to the EJP-CONCERT (2015-2020). This statement highlights a focused number of priorities for funding. Research in radioecology and related sciences is justified by various drivers, such as policy changes, scientific advances and knowledge gaps, radiological risk perception by the public, and a growing awareness of interconnections between human and ecosystem health. The SRA is being complemented by topical roadmaps that have been initiated by the COMET EC-funded project, with the help and endorsement of the ALLIANCE. The strategy underlying roadmap development is driven by the need for improved mechanistic understanding across radioecology. By meeting this need, we can provide fit-for-purpose human and environmental impact/risk assessments in support of the protection of man and the environment in interaction with society and for the three exposure situations defined by the ICRP (i.e., planned, existing and emergency). Within the framework of the EJP-CONCERT the development of a joint roadmap is under discussion among all the European research platforms and will highlight the major research needs for the whole radiation protection field and how these are likely to be addressed by 2030.

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6498/aa9c0aDOI Listing

Publication Analysis

Top Keywords

topical roadmaps
8
alliance strategic
8
strategic agenda
8
comet supported
4
supported development
4
development implementation
4
implementation medium-term
4
medium-term topical
4
roadmaps consistent
4
alliance
4

Similar Publications

Piperine, quercetin, and curcumin identified as promising natural products for topical treatment of cutaneous leishmaniasis.

Parasitol Res

April 2024

Instituto Académico Pedagógico de Ciencias Humanas, Universidad Nacional de Villa María, Campus Universitario, Av. Arturo Jauretche 1555, CP 5900, Villa María, Argentina.

Leishmania braziliensis (L. braziliensis) causes cutaneous leishmaniasis (CL) in the New World. The costs and the side effects of current treatments render imperative the development of new therapies that are affordable and easy to administer.

View Article and Find Full Text PDF

Background: Cutaneous leishmaniasis (CL) is a common, yet massively underreported skin morbidity in Ethiopia. Most patients never seek treatment, as this is offered only in specialized treatment centers. Early diagnosis and treatment through decentralization is crucial to decrease transmission and to reach the NTD roadmap goals.

View Article and Find Full Text PDF

Congenital Ichthyosis: A Practical Clinical Guide on Current Treatments and Future Perspectives.

Clin Cosmet Investig Dermatol

September 2023

Department of Dermatology and Program in Translational Biomedicine, Yale School of Medicine, New Haven, CT, 06520, USA.

Congenital ichthyoses are a group of hereditary disorders of keratinization that are challenging to treat. Affected individuals suffer not only from thickening of the skin but also associated complications such as growth restriction, hearing and eye complications, infections, and thermodysregulation. This clinical review provides a practical roadmap to the longitudinal care of patients with ichthyosis with both general and age- and disease-specific recommendations.

View Article and Find Full Text PDF

Next Generation Sequencing Revolutionizes Organismal Biology Research in Bats.

J Mol Evol

August 2023

Centre for Climate Change and Sustainability (3CS), Ashoka University, Sonipat, Haryana, 131029, India.

The advent of next generation sequencing technologies (NGS) has greatly accelerated our understanding of critical aspects of organismal biology from non-model organisms. Bats form a particularly interesting group in this regard, as genomic data have helped unearth a vast spectrum of idiosyncrasies in bat genomes associated with bat biology, physiology, and evolution. Bats are important bioindicators and are keystone species to many eco-systems.

View Article and Find Full Text PDF

A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis.

Cytotherapy

August 2023

Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore C/O NUHS Tower Block, Singapore, Republic of Singapore. Electronic address:

The most clinically trialed cells, mesenchymal stromal cells (MSCs), are now known to mainly exert their therapeutic activity through paracrine secretions, which include exosomes. To mitigate potential regulatory concerns on the scalability and reproducibility in the preparations of MSC exosomes, MSC exosomes were produced using a highly characterized MYC-immortalized monoclonal cell line. These cells do not form tumors in athymic nude mice or exhibit anchorage-independent growth, and their exosomes do not carry MYC protein or promote tumor growth.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!